No Detail Found!

Long-Term Outcomes of Drug-Coated Balloon Angioplasty in The Treatment of Small Vessel Coronary Artery Disease

Author(s)
Mujtaba Ahmed Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Khawar Naeem Satti Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Asim Javed Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Fatima Noor Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Muhammad Mohsin Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
Aimen Javed 6Weil Cornell Medical College, Qatar
Abstract
Objectives: To determine the outcomes in patients with small-vessel disease (SVD) who underwent percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB) and correlate these adverse outcomes with various risk factors. Methodology: The prospective cohort study was conducted at the Rawalpindi Institute of Cardiology (RIC) from January 2020 to December 2022. After being approved by the Hospital Ethics Committee, fifty-four patients who presented with SVD were enrolled using non-probability consecutive sampling. Written informed consent was obtained from the patients. They were treated with DCB and observed clinically on follow-ups at 15, 30, 60, and 90 days, & later after every 6 months for up to 2 years. Only those patients who presented with symptoms underwent repeat angiography. The outcomes assessed were cardiovascular mortality, myocardial infarction (MI), and target lesion revascularization (TLR). Results: Cardiovascular mortality occurred in 2(3.7%), MI in 3(5.6%) and TLR in 2(3.7%) patients. There was a significant association between cardiovascular mortality, MI, and TLR with diabetes mellitus and BMI. Age was only significantly related to cardiovascular mortality. Conclusion: A drug-coated balloon is an effective and feasible treatment modality for small vessel disease. The incidence of outcomes of cardiovascular mortality, MI, and TLR after DCB is low, making it a safe modality. Advanced age, obesity, and diabetes mellitus alone or with hypertension are the predicting factors of adverse outcomes after DCB in patients with SVD.
Publication Details
Page(s) 57-62
Published Journal: Annals of the Pakistan Institute of Medical Sciences, Volume: 19, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
SVD, DCB, Small vessel coronary artery disease, Drug-coated balloon
0

Citations

0

Downloads

168

Views